79
Participants
Start Date
January 6, 2015
Primary Completion Date
March 5, 2016
Study Completion Date
March 5, 2016
GSK2982772 solution
Clear, colorless solution containing GSK2982772 in water with 5% ethanol (0.1mg/mL). Administered orally in required volumes for dosing less than 5mg
GSK2982772 capsule
Size 00 White Opaque capsule containing GSK2982772 as white to almost white solid. Administered orally with water for dosing from 5 to 120 mg
Placebo solution
Clear, colorless solution containing placebo in water with 5% ethanol (0.1mg/mL). Administered orally in required volumes for dosing less than 5mg
Placebo capsule
Size 00 White Opaque capsule containing Placebo as white to almost white solid
GSK Investigational Site, Cambridge
Lead Sponsor
Clinical Unit at Cambridge (Addenbrooks)
UNKNOWN
GlaxoSmithKline
INDUSTRY